Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Nov 5 - Nov 10
Journal of Endocrinology and Metabolism, 107 (4), 621-629
The drugs multifaceted impact on metabolism, body fat, and general well-being makes it a compelling choice for those who require more than lifestyle interventions
Wegovy is approved for weight loss in South Africa Ozempic is approved for type-2 diabetes but may be prescribed off-label for weight loss
Message & data rates may apply
After a dose-titration and dose-stable run-in period of up to 16 weeks and a 2-week placebo run-in period, patients with inadequate glycemic control (A1C 7.5% to 10.5%) were randomized to the addition of either 100 mg of sitagliptin or placebo, administered once daily
US$ 26.33
US$ 27.71
US$ 24.79
